---
title: "DC 6839 - Mucormycosis"
diagnostic_code: "6839"
body_system: "Respiratory System"
cfr_section: "§ 4.97"
canonical: "https://veteranai.co/va-rating-schedule/respiratory/6839-mucormycosis"
source: "https://www.ecfr.gov/current/title-38/section-4.97"
updated: "2026-07-21T18:20:01.720495Z"
---

# DC 6839 - Mucormycosis

Rated under § 4.97. Body system: Respiratory System.

General Rating Formula for Mycotic Lung Disease (diagnostic codes 6834 through 6839)

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Chronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis |
| 50% | Chronic pulmonary mycosis requiring suppressive therapy with no more than minimal symptoms such as occasional minor hemoptysis or productive cough |
| 30% | Chronic pulmonary mycosis with minimal symptoms such as occasional minor hemoptysis or productive cough |
| 0% | Healed and inactive mycotic lesions, asymptomatic |

## Notes

- Note: Coccidioidomycosis has an incubation period up to 21 days, and the disseminated phase is ordinarily manifest within six months of the primary phase. However, there are instances of dissemination delayed up to many years after the initial infection which may have been unrecognized. Accordingly, when service connection is under consideration in the absence of record or other evidence of the disease in service, service in southwestern United States where the disease is endemic and absence of prolonged residence in this locality before or after service will be the deciding factor.

# Mucormycosis (VA Diagnostic Code 6839)

## Understanding Your VA Rating for Mucormycosis

Mucormycosis is a fungal (mycotic) lung disease affecting the **respiratory system**. The VA rates this condition under **Diagnostic Code 6839**, found in **§ 4.97** of the rating schedule, using the **General Rating Formula for Mycotic Lung Disease**.

This entry explains how the VA structures its rating levels for this condition and what the VA looks for at each level. It is provided for general information only and does not predict any individual outcome.

---

## Plain-Language Overview

Mucormycosis is a type of fungal infection that can affect the lungs. When the VA evaluates a claim for this condition, it looks at how active the disease is and how significantly its symptoms affect you — ranging from healed, inactive lesions with no symptoms to chronic disease with serious symptoms.

---

## Available Rating Levels

The VA assigns one of the following disability ratings based on the severity and symptoms of the condition:

### 100% Rating
Chronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis (coughing up blood).

### 50% Rating
Chronic pulmonary mycosis requiring suppressive therapy with no more than minimal symptoms, such as occasional minor hemoptysis or productive cough.

### 30% Rating
Chronic pulmonary mycosis with minimal symptoms, such as occasional minor hemoptysis or productive cough.

### 0% Rating
Healed and inactive mycotic lesions that are asymptomatic (no symptoms).

---

## What the VA Looks For

When rating this condition, the VA focuses on:

- **Whether the disease is active or healed** — Healed, inactive, and asymptomatic lesions are rated at 0%.
- **The presence and severity of symptoms** — such as fever, weight loss, night sweats, hemoptysis (coughing up blood), and productive cough.
- **Whether suppressive therapy is required** — needing suppressive therapy while having no more than minimal symptoms is a factor at the 50% level.
- **The intensity of symptoms** — for example, distinguishing "minimal symptoms" (such as occasional minor hemoptysis or productive cough) from more serious presentations like persistent fever or massive hemoptysis.

---

## Special Note on Service Connection

The rating schedule includes the following note relevant to related mycotic conditions:

> Coccidioidomycosis has an incubation period up to 21 days, and the disseminated phase is ordinarily manifest within six months of the primary phase. However, there are instances of dissemination delayed up to many years after the initial infection which may have been unrecognized. Accordingly, when service connection is under consideration in the absence of record or other evidence of the disease in service, service in the southwestern United States where the disease is endemic and absence of prolonged residence in this locality before or after service will be the deciding factor.

---

*This information is based on the VA rating schedule under § 4.97, Diagnostic Code 6839. It is provided for general educational purposes and is not a guarantee of any rating result.*

Source: https://www.ecfr.gov/current/title-38/section-4.97